Epigenomic Disruption in Brain Cells Drives Alzheimer’s Cognitive Decline
TL;DR
A large-scale study reveals that Alzheimer's disease involves fundamental breakdowns in epigenomic control within brain cells, leading to gene expression dysregulation and cognitive decline, suggesting new treatment avenues targeting genome stability.
- Alzheimer’s Linked to Epigenomic Breakdown, Not Just Plaques Neuroscience News
- Single-Cell Atlas Links Epigenomic Decline to Cognitive Loss Technology Networks
- When Brain Cells Lose Their Grip, Memory Follows ScienceBlog.com
- MIT Study Links Alzheimer’s Cognitive Decline to Disrupted Gene Regulation in Brain Cells geneonline.com
Want the full story? Read the original reporting
Read on Neuroscience News